✦ LIBER ✦

Phase II study with Taxol® (paclitaxel) and Gemzar® (gemcitabine) in metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Douillard, J.Y; Lerouge, D; Monnier, A; Sun, X.S; Haller, M.A; Assouline, D; Grau, B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of taxol and gemcitabine

✍ Auerbach, M; Chaudhry, M; Richards, P; Clinthorne, D 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase II study of gemcitabine in non sma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemcitabine, ifosfamide and paclitaxel i

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

Gemcitabine in locally advanced and meta

✍ Zatloukal, P; Kanitz, E; Magyar, P; Jassem, J; Krzakowski, M; Pawlikci, M; Petru 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 130 KB

P-585 Carboplatin plus gemcitabine follo

✍ Tjan-Heijnen, V.; Timmer-Bonte, J.; van der Drift, M.; van Leeuwen, F.; de Boo, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Paclitaxel, gemcitabine, and cisplatin i

✍ Sorensen, Jens B.; Stenbygaard, Lars Erik; Osterlind, Kell; Hansen, Heine Høi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB